Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5189051 | 0.90 | ADRB2 (0.44) | ADRB2ADRB1 | |
| SCHEMBL5165194 | 0.85 | ADRB2 (0.65) | ADRB2ADRB1 | |
| SCHEMBL20321903 | 0.82 | ADRB2 (0.54) | ADRB2ADRB1 | |
| Fumaric Acid SCHEMBL5582503 | 0.81 | ADRB2 (0.59) | ADRB2ADRB1 | |
| SCHEMBL564792 | 0.81 | ADRB2 (0.73) | ADRB2ADRB1 | |
| SCHEMBL12594506 | 0.81 | ADRB2 (0.54) | ADRB2ADRB1 | |
| SCHEMBL561768 | 0.80 | ADRB2 (0.53) | ADRB2ADRB1 | |
| Hydrochloric Acid SCHEMBL5582900 | 0.79 | ADRB2 (0.68) | ADRB2ADRB1 | |
| SCHEMBL5164807 | 0.78 | ADRB2 (0.56) | ADRB2ADRB1 | |
| SCHEMBL3908050 | 0.78 | ADRB2 (0.64) | ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1809293-A2 | AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2007-07-25 | — | — | EP | disclosed |
| WO-2005110421-A2 | AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
| EP-1562603-A2 | NOVEL MEDICAMENTS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES | Boehringer Ingelheim Pharma GmbH & Co.KG (DE) | 2005-08-17 | — | — | EP | disclosed |
| WO-2004045618-A2 | NOVEL MEDICAMENTS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-06-03 | — | — | WO | disclosed |